RT Journal Article SR Electronic T1 Methylphenidate use and restorative treatment in 13,000 young adults with ADHD JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.04.21.20074567 DO 10.1101/2020.04.21.20074567 A1 Haggai Schermann A1 Nathan Schiffmann A1 Ran Ankory A1 Amir Shlaifer A1 Victoria Yoffe A1 Lena Natapov YR 2020 UL http://medrxiv.org/content/early/2020/04/24/2020.04.21.20074567.abstract AB Background Previous research has shown that children with Attention Deficit and Hyperactivity Disorder (ADHD) have poor oral health compared to healthy children. Methylphenidate (MP), a widely used stimulant medication for ADHD, was believed to be involved in caries pathophysiology by causing xerostomia. However, a few prospective studies failed to confirm that MP has an independent effect on oral health.Methods This study is a retrospective cohort of military recruits ages 18-25 who served for 12 to 48 months between 2005 and 2017. The cohort included 6,875 subjects with ADHD who received treatment with MP (“Treated”), 6,729 subjects with ADHD who had no prescriptions for MP (“Untreated”) and 200,000 healthy controls. Exposure to MP was measured as total amount of medication in gr, prescribed during the study period. The outcome was normative treatment needs: having at least one recommendation for restorative treatment during the study period.Results Frequency of recommendation for restorative treatment among the treated, the untreated and the control groups was 24%, 22% and 17%, respectively (p<0.0001). On multivariate analysis, the dose-response association between MP use and the odds of having at least one restorative treatment was confirmed (OR=1.006 for each additional 1 gr of MP; 95% CI [1.004:1.009]).Conclusions This study represents the first ecological evidence of a dose-response effect of MP use on incidence of restorative treatment needs.Clinical significance Subjects with ADHD who receive chronic treatment with MP have higher restorative treatment needs than subjects with untreated ADHD and healthy controls. Our results show that chronic MP medication among young adults leads to an elevated need for restorative treatment and implies a significant impact on oral health.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNot available